111 related articles for article (PubMed ID: 1705477)
1. Human carcinoma cells express receptors for distinct domains of thrombospondin.
Yabkowitz R; Dixit VM
Cancer Res; 1991 Mar; 51(6):1645-50. PubMed ID: 1705477
[TBL] [Abstract][Full Text] [Related]
2. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
Yabkowitz R; Dixit VM
Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
[TBL] [Abstract][Full Text] [Related]
3. Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.
Yabkowitz R; Mansfield PJ; Dixit VM; Suchard SJ
Cancer Res; 1993 Jan; 53(2):378-87. PubMed ID: 8417830
[TBL] [Abstract][Full Text] [Related]
4. Activation of human neutrophils increases thrombospondin receptor expression.
Suchard SJ; Boxer LA; Dixit VM
J Immunol; 1991 Jul; 147(2):651-9. PubMed ID: 1712815
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin promotes both chemotaxis and haptotaxis in neutrophil-like HL-60 cells.
Mansfield PJ; Suchard SJ
J Immunol; 1993 Mar; 150(5):1959-70. PubMed ID: 8436828
[TBL] [Abstract][Full Text] [Related]
7. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
Dardik R; Lahav J
Biochemistry; 1991 Sep; 30(38):9378-86. PubMed ID: 1716458
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin stimulates motility of human neutrophils.
Mansfield PJ; Boxer LA; Suchard SJ
J Cell Biol; 1990 Dec; 111(6 Pt 2):3077-86. PubMed ID: 2269666
[TBL] [Abstract][Full Text] [Related]
9. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.
Mikhailenko I; Krylov D; Argraves KM; Roberts DD; Liau G; Strickland DK
J Biol Chem; 1997 Mar; 272(10):6784-91. PubMed ID: 9045712
[TBL] [Abstract][Full Text] [Related]
10. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain.
Yabkowitz R; Lowe JB; Dixit VM
J Biol Chem; 1989 Jun; 264(18):10888-96. PubMed ID: 2659597
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes.
Mansfield PJ; Suchard SJ
J Immunol; 1994 Nov; 153(9):4219-29. PubMed ID: 7930624
[TBL] [Abstract][Full Text] [Related]
12. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-controlled synthesis and binding of thrombospondin to granulosa cells.
Dreyfus M; Dardik R; Suh BS; Amsterdam A; Lahav J
Endocrinology; 1992 May; 130(5):2565-70. PubMed ID: 1374008
[TBL] [Abstract][Full Text] [Related]
14. Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.
Asch AS; Tepler J; Silbiger S; Nachman RL
J Biol Chem; 1991 Jan; 266(3):1740-5. PubMed ID: 1703153
[TBL] [Abstract][Full Text] [Related]
15. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
[TBL] [Abstract][Full Text] [Related]
16. Modulation of thrombospondin receptor expression during HL-60 cell differentiation.
Suchard SJ; Mansfield PJ; Dixit VM
J Immunol; 1994 Jan; 152(2):877-88. PubMed ID: 7506739
[TBL] [Abstract][Full Text] [Related]
17. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.
Silverstein RL; Baird M; Lo SK; Yesner LM
J Biol Chem; 1992 Aug; 267(23):16607-12. PubMed ID: 1379600
[TBL] [Abstract][Full Text] [Related]
18. Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule.
Prochownik EV; O'Rourke K; Dixit VM
J Cell Biol; 1989 Aug; 109(2):843-52. PubMed ID: 2760115
[TBL] [Abstract][Full Text] [Related]
19. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36.
Li WX; Howard RJ; Leung LL
J Biol Chem; 1993 Aug; 268(22):16179-84. PubMed ID: 7688364
[TBL] [Abstract][Full Text] [Related]
20. Monocyte killing of human squamous epithelial cells: role for thrombospondin.
Riser BL; Mitra R; Perry D; Dixit V; Varani J
Cancer Res; 1989 Nov; 49(21):6123-9. PubMed ID: 2676156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
